Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

About IAVI’s Lassa virus vaccine program

IAVI and our partners are developing a single-dose vaccine candidate for protection against Lassa virus (LASV). No vaccine is yet approved to prevent Lassa fever, the illness caused by LASV.

Read more

About IAVI’s Marburg virus vaccine program

IAVI is developing a vaccine candidate for protection against Marburg virus (MARV), a deadly pathogen and potential bioweapon that repeatedly causes severe outbreaks.

Read more

About IAVI’s Sudan virus vaccine program

IAVI is developing a vaccine candidate for protection against Sudan virus (SUDV) and has contributed to outbreak responses in sub-Saharan Africa. 

Read more

Features

Fast facts about IAVI’s contributions to fighting Lassa fever in West Africa

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Lassa virus, since 2018.

Read more

Features

Fast facts about the preclinical data supporting IAVI’s Marburg virus vaccine candidate

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Marburg virus, since 2018.

Read more

Features

Frequently asked questions: Lassa fever

September 11, 2025

Learn more about Lassa virus, a zoonotic virus that causes severe hemorrhagic fever in humans.

Read more

Features

Frequently asked questions: Marburg virus disease

September 11, 2025

Learn more about Marburg virus, a filovirus that causes a severe hemorrhagic illness in humans.

Read more

Features

Frequently asked questions: Sudan virus disease

September 11, 2025

Learn more about Sudan virus, a filovirus that causes severe hemorrhagic illness in humans.

Read more